5’aza therapy increased IFN-ɣ signature and PD-L1 expression and decreased NLR, which correlated with prolonged OS, in R/M HNSCC patients previously refractory to ICB. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.